Teva Pharmaceutical Industries Ltd.
↗Tel Aviv, Israel
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, headquartered in Israel. The company is the world's largest generic drug manufacturer and maintains a significant portfolio of innovative medicines in neuroscience, oncology, and respiratory health. Teva's 'Pivot to Growth' strategy focuses on expanding its innovative pipeline and biosimilars while maintaining its leadership in the global generics market.
In India, Teva operates through several legal entities with a massive footprint in manufacturing and R&D. The Indian division is a critical hub for the global supply chain, operating multiple API and finished dosage plants in locations like Goa, Ambernath, and Gajraula, alongside major R&D centers in Noida.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics and Specialty Biopharma
SIZE & FINANCIALS
Employees:10000+
Revenue:$16.5B - $17.3B
Founded:1901
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Institutional investors including Berkshire Hathaway (formerly), Capital Research Global Investors, Vanguard Group
STOCK
Exchange:NYSE
Ticker:TEVA
Market Cap:$18.5B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Austedo, Ajovy)
Modalities:Small molecule, Biosimilar, mAb, Long-acting Injectables (LAI)
Active Trials:854
Trial Phases:Phase 1: 12 | Phase 2: 15 | Phase 3: 10 | Phase 4: 25
FDA Approvals:150
EMA Approvals:120
CORPORATE STRUCTURE
Subsidiaries:Teva Pharmaceuticals USA, Teva Pharmaceutical & Chemical Industries India Pvt Ltd, Actavis Generics, Anda Inc.
Key Partnerships:Sanofi (Duvakitug collaboration), Royalty Pharma (Anti-IL-15 funding), MedinCell (Uzedy development)
COMPETITION
Position:Leader
Competitors:Sandoz, Viatris, Hikma Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories
LEADERSHIP
Key Executives:
Richard Francis - President and CEO
Eli Kalif - CFO
Dr. R. Ananthanarayanan - CEO, Teva API
Scientific Founders:Günther Friedländer
Board Members:Sol J. Barer (Chairman), Rosemary A. Crane, Varda Shalev
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Teva Pharmaceutical Industries Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.